Amyloidosis can affect any organ in the body by deposition of amyloid fibrils. When these aggregate in the heart, it leads to cardiac amyloidosis a life-threatening and progressive disease. Although considered a rare condition, advances in imaging techniques and raised awareness have shown that it might be more frequent than has been historically estimated. Cardiac amyloidosis can be hereditary or occur as a consequence of the ageing process but, regardless of type, patients experience a heavy symptomatic burden. This article provides an overview of its pathophysiology, signs and symptoms and how any nurse can look for the main red flags in clinical practice. Early referral for specialist care can have a significant impact on disease progression and patient quality of life.
Keyphrases
- multiple myeloma
- left ventricular
- clinical practice
- end stage renal disease
- palliative care
- primary care
- high resolution
- ejection fraction
- newly diagnosed
- healthcare
- chronic kidney disease
- multiple sclerosis
- prognostic factors
- peritoneal dialysis
- case report
- atrial fibrillation
- risk factors
- quality improvement
- depressive symptoms
- pain management
- physical activity
- mass spectrometry
- photodynamic therapy
- chronic pain
- health insurance